1. Medtech Insight

Into 2019: Intelligent Innovation's Role In The Shape Of Medtech Things To Come

 
• By Ashley Yeo

Brexit, the "Implant Files" and the new EU regulations – however large they loom at present, they will in time be seen as mere tactical challenges for a global medtech industry working hard to ensure that it is ready for the massive health-care delivery and service-oriented changes to come. Preparing for the future and maximizing current market penetration – in the UK, the EU and beyond – were key themes at UK HealthTech 2018, held in Cardiff, Wales.

A desert road with the inscription 2018 2019. Concept of the departing old year and new goals. - Image

Health-care delivery is changing at an ever-faster pace, and predictions made now for four years hence may well prove to be inaccurate. Such is the lot of those who set themselves the task of looking into the future.

Deloitte's UK Centre for Healthcare Solutions' Mark Steedman took up that challenge this year in co-compiling the flagship "Future Awakens" report, Deloitte's attempt to char how health care will look...

The Deloitte report is a study of current health-care trends and a distillation of the findings into six key themes that the consultants believe will have a major influence...

More from Digital Technologies

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.